Dexcom (DXCM) EBT Margin (2010 - 2026)

Dexcom (DXCM) has 17 years of EBT Margin data on file, last reported at 22.61% in Q1 2026.

• EBT Margin for Q1 2026 came in at 22.61%, up 772.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 24.98% (up 736.0% YoY), and the FY2025 annual result was 23.35%, up 577.0% from the prior year.
• EBT Margin declined to 22.61% in Q1 2026 per DXCM's latest filing, from 27.05% in the prior quarter.
• Over five years, EBT Margin peaked at 29.13% in Q3 2025 and troughed at 5.74% in Q1 2022.
• A 5-year average of 18.34% and a median of 18.7% in 2024 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2022 and 2024: EBT Margin jumped 1542 bps in 2022, then tumbled 681 bps in 2024.
• A 5-year view of EBT Margin shows it stood at 16.34% in 2022, then soared by 46 bps to 23.8% in 2023, then declined by 20 bps to 18.98% in 2024, then surged by 43 bps to 27.05% in 2025, then decreased by 16 bps to 22.61% in 2026.
• Business Quant data shows DXCM's EBT Margin at 22.61% in Q1 2026, 27.05% in Q4 2025, and 29.13% in Q3 2025.